Individualizing Gentamicin Dosage Regimens in Burn Patients with Gram-Negative Septicemia: A Cost–Benefit Analysis
- 1 March 1979
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 68 (3), 267-272
- https://doi.org/10.1002/jps.2600680304
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The Social Impact of Pharmaceutical InnovationDrug Development and Industrial Pharmacy, 1977
- INCREASED DOSAGE REQUIREMENTS OF GENTAMICIN IN BURN PATIENTSPublished by Wolters Kluwer Health ,1976
- The Evolution of the Clinical Pharmacy ConceptDrug Intelligence & Clinical Pharmacy, 1976
- Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: Gentamicin in burn patientsJournal of Pharmacokinetics and Biopharmaceutics, 1976
- Experience in Monitoring Gentamicin Therapy during Treatment of Serious Gram-Negative SepsisBMJ, 1974
- Chronic liver disease associated with childhood ulcerative colitisPostgraduate Medical Journal, 1974
- Present status of cost-benefit analysis in the health field.American Journal of Public Health and the Nations Health, 1967